Hosted on MSN27m
Newly FDA-approved non-opioid painkiller is first of its kind in over 20 years
For the first time in 20 years, the Food and Drug Administration has approved a new pharmaceutical approach to treating pain.
Dr. Gupta details new FDA-approved pain medication with no opioids
The US Food and Drug Administration signed off on the first new type of pain reliever to be approved in more than two decades ...
FDA approved the first new kind of pain medication in 27 years. Here’s how it works
The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...
Yale Daily News1d
First FDA-approved non-addictive painkiller has Yale roots
Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.
Cure Today2d
FDA-Approved Calquence Combo Is First and Only of Its Kind in MCL
Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...
Medical News Today11d
FDA-approved nasal spray for severe depression can lead to remission
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
CBS 58 News2d
FDA-approved blood test detecting colon cancer hopes to increase screening rates
The gold standard colonoscopy is still the preferred method for finding colon cancer, but on this World Cancer Day, we're hearing more about a simple blood test that could get more ...
StudyFinds on MSN5d
Journavx: What to know about new FDA-approved non-opioid pain medication
Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
Philadelphia doctor excited after world's smallest heart pump now FDA-approved for kids
New high-tech help for young heart patients has been approved by the U.S. Food and Drug Administration. Doctors say this will ...
New Atlas7d
"Kick and kill": HIV cure could be hiding in FDA-approved drug
HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...
Business Wire3d
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...